GlassScriptPhysician profile
Steven Tucker
NPI 1548655608
$1,584.75
in general payments reported to CMS, 2019-2025
17 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.77 · 2020: $113 · 2021: $140 · 2022: $47.18 · 2023: $521 · 2024: $294 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.09 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $375.35 | 2023 | |
| Abbvie INC. | $299.08 | 2024-2025 | |
| Alcon Vision LLC | $283.24 | 2019-2025 | Clareon |
| Sun Pharmaceutical Industries INC. | $240.84 | 2020-2025 | Cequa |
| Ocular Therapeutix, INC. | $63.07 | 2021-2023 | Dextenza |
| Harrow Eye, LLC | $49.06 | 2024 | Iheezo, Vevye |
| Mallinckrodt Hospital Products INC. | $48.44 | 2020-2024 | Acthar |
| Oyster Point Pharma, INC. | $39.22 | 2023 | Tyrvaya |
| Rxsight INC | $38.86 | 2025 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Tearlab Corp | $32.10 | 2019-2024 | Scoutpro Osmolarity System |
| Horizon Therapeutics Plc | $20.74 | 2023 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $17.53 | 2025 | Tecnis Iol |
| Sight Sciences, INC. | $16.82 | 2024 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $16.72 | 2023 | |
| Kala Pharmaceuticals, INC. | $15.18 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $15.02 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.